Ahmet Akif KIZILKURTLU

Dr. Ahmet Akif KIZILKURTLU

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2023 in Biotechnology and Applied Biochemistry
Verified
Journal Article
Open access
AKAhmet Akif KIZILKURTLU
Ahmet Akif KIZILKURTLU
EDErhan Demirbas
Erhan Demirbas
HAHatice Esra Agel
Hatice Esra Agel
A biosensor system refers to a biomedical device, which detects biological, chemical, or biochemical components by converting those signals to an electrical signal by utilizing and uniting physical or chemical transducer with biorecognition elements. An electrochemical biosensor is generally based on the reaction of either production or consumption of electrons under a three‐electrode system. Biosensor systems are exploited in a wide range of areas, such as medicine, agriculture, husbandry, food, industry, environment protection, quality control, waste disposal, and the military. Pathogenic infections are the third leading cause of death worldwide after cardiovascular diseases and cancer. Therefore, there is an urgent need for effective diagnostic tools to control food, water, and soil contamination result in protecting human life and health. Aptamers are peptide or oligonucleotide‐based molecules that show very high affinity to their targets that are produced from large pools of random amino acid or oligonucleotide sequences. Generally, aptamers have been utilized for fundamental sciences and clinical implementations for their target‐specific affinity and have been intensely exploited for different kinds of biosensor applications for approximately 30 years. The convergence of aptamers with biosensor systems enabled the construction of voltammetric, amperometric, and impedimetric biosensors for the detection of specific pathogens. In this review, electrochemical aptamer biosensors were evaluated by discussing the definition, types, and production techniques of aptamers, the advantages of aptamers as a biological recognition element against their alternatives, and a wide range of aptasensor examples from literature in the detection of specific pathogens.

23 March 2026 in Biosensors
Verified
Journal Article
Open access
PDF file
RMRoy Merkezoğlu
Roy Merkezoğlu
OYOzgur Yılmaz
Ozgur Yılmaz
AKAhmet Akif KIZILKURTLU
Ahmet Akif KIZILKURTLU
Electrochemical biosensors integrated into wearable devices have revolutionized the technology in terms of health monitoring and diagnostic systems. However, when it comes to moving the devices from the laboratory to real-world environments, a critical problem emerges with the interface. The problem, in essence, is that biorecognition elements tend to lose their activity, delaminate, and drift when exposed to various environmental stresses. The traditional methods for the immobilization of the biorecognition elements result in receptors with random orientations, hydrolytically unstable bonds, and batch-to-batch variability, regardless of the method, including physisorption or non-selective covalent attachment, like using EDC/NHS. This review is organized around a comparative question: which limitations of classical immobilization strategies (physisorption, self-assembled monolayers used as passive anchoring platforms, and EDC/NHS coupling) can be resolved by click chemistry, which can be resolved by mechanistic features? Accordingly, CuAAC, SPAAC, IEDDA, and thiol-ene/yne photoclick reactions are discussed, not as an isolated catalog of ligations, but as complementary solutions to specific interfacial failure modes, including random bioreceptor orientation, hydrolytically vulnerable attachment, poor batch reproducibility, catalyst sensitivity, and the difficulty of functionalizing soft polymeric or textile substrates. In this framework, click chemistry is treated as a deterministic interface-engineering strategy that enables defined covalent fixation, programmable probe density, and improved mechanical and electrochemical robustness under wearable operating conditions.

Verified
Journal Article
Open access
PDF file
AKAhmet Akif KIZILKURTLU
Ahmet Akif KIZILKURTLU
OYOzgur Yılmaz
Ozgur Yılmaz
Cutaneous tissue engineering has advanced from simple coverage substitutes to increasingly complex living constructs, yet the field remains constrained by a decisive problem: timely and durable perfusion. Many engineered skin substitutes can appear vascular in static culture or in small-animal models. However, they still fail when blood flow must be established quickly enough to rescue cells across clinically relevant tissue thickness. Rather than re-catalog platforms already summarized in recent reviews, this critical narrative review reframes the field around perfusion as the master functional endpoint rather than vessel density alone. We analyze the vascularization bottleneck as a sequence, internal network formation, host inosculation, flow initiation, and perfusion stability—and use that sequence to reassess biomaterial design, cell-based strategies, immunomodulation, decellularized matrices, bioprinting, microfluidics, and prevascularization. We intentionally distinguish implantable skin substitutes from perfused in vitro platforms such as skin-on-chip systems, arguing that these are linked but non-interchangeable application spaces with different success criteria. Building on this distinction, we propose a research agenda centered on functional benchmarking of perfusion, spatiotemporal coordination of scaffold dynamics, immune–mural–lymphatic–vascular crosstalk, scalable hierarchical vascular fabrication, and predictive human test platforms. The central argument is that translation will depend not on ever more isolated pro-angiogenic interventions but on integrated systems that survive the ischemic interval, connect rapidly, tolerate blood entry, maintain a workable inflow–outflow balance, and remodel into a stable, skin-specific microvasculature.

6 August 2026 in Acta Biomaterialia
Verified
Journal Article
Open access
AMAmirhossein Moghanian
Amirhossein Moghanian
AKAhmet Akif KIZILKURTLU
Ahmet Akif KIZILKURTLU
APArang Pazhouheshgar
Arang Pazhouheshgar
MEMohammad Nasr Esfahani
Mohammad Nasr Esfahani
AAAli Akpek
Ali Akpek
Håvard Jostein HaugenHåvard Jostein Haugen
Håvard Jostein Haugen

29 July 2026 in Polymers
Verified
Journal Article
Open access
PDF file
TATubanur Avcı
Tubanur Avcı
EAEray Altan
Eray Altan
CACeren Aytar
Ceren Aytar
ZKZehra Kanlı
Zehra Kanlı
EKElif Kaya
Elif Kaya
AKAhmet Akif KIZILKURTLU
Ahmet Akif KIZILKURTLU
Melanoma excision procedures frequently result in complex wounds that require simultaneous tumor suppression and tissue regeneration. However, current post-surgical care heavily relies on synthetic drugs, facing challenges like antibiotic resistance and delayed healing. To address this notable gap, this study introduces a novel “mineral-botanical” hybrid nanofibrous dressing to reduce reliance on conventional synthetic agents. The nanofiber surfaces were subsequently functionalized with a supercritical CO2 extract of Inula helenium, thereby introducing a highly bioactive botanical agent not previously explored in this hybrid wound-care context. Comprehensive physical and structural characterizations demonstrated that the bioactive coating serves as a resilient physical barrier, significantly enhancing the dressing’s structural integrity in fluidic environments. In vitro biological evaluations revealed a dual-action mechanism: the biomaterial exhibited excellent biocompatibility and accelerated migration in human dermal fibroblasts (HDFs), achieving nearly 100% in vitro wound closure at 24 h. Conversely, the Inula helenium-coated nanofibers demonstrated distinct, selective cytotoxicity against A375 melanoma cells, effectively restricting their proliferation and reducing their viability. Furthermore, the hybrid platform exhibited significant antioxidant potential and achieved 94% antibacterial inhibition against Staphylococcus aureus. In conclusion, this study presents a sustainable, dual-function wound dressing that suppresses residual cancer cells while promoting healthy tissue regeneration, offering a promising alternative to conventional synthetic oncological dressings.

18 August 2026 in Biosensors
Verified
Journal Article
Open access
PDF file
AKAhmet Akif KIZILKURTLU
Ahmet Akif KIZILKURTLU
AAAli AKPEK
Ali AKPEK
Continuous glucose monitoring has established that a molecular signal can be repeatedly measured in daily life and translated into clinically meaningful action. The next frontier is broader: wearable biosensors that monitor metabolites, electrolytes, hormones, drugs, nutrients, inflammatory markers, and tissue-state indicators beyond glucose. This review proposes an artificial intelligence (AI)-ready framework for multimodal wearable biochemical monitoring. We organize the field as a complete measurement chain that links biofluid access, sampling chronology, flexible biointerfaces, molecular recognition, signal conditioning, metadata capture, sensor fusion, clinical validation, and lifecycle governance. The central argument is that the clinically useful variable is rarely a raw current, potential, optical intensity, or spectrum; it is a quality-controlled, context-aware, and uncertainty-aware digital biomarker. We compare sweat, interstitial fluid, saliva, tears, wound exudate, and breath condensate; evaluate enzymatic, ion-selective, affinity, transistor, optical, and spectroscopic sensing strategies; synthesize representative high-impact studies; and define minimum metadata, validation metrics, and translation gates. The review highlights recurring gaps in biofluid validity, real-world robustness, reference-comparator alignment, subgroup evidence, and algorithmic governance. We conclude with practical design rules for converting flexible biochemical wearables from attractive prototypes into clinically credible intelligent biosensing systems.